IBDX ETF Analysis: Trust - iBonds Dec 2032 | NYSE

Target Maturity Bonds | NYSE, USA | Market Cap: 1.798m USD | 12M Return: 0.1% | US46436E3128 | Charts, Fundamentals & Technical Analysis

Corporate Bonds, Fixed Income, Target Maturity, Investment Grade
Total Rating 36
Safety 62
Buy Signal -0.24
Target Maturity Bonds
Category Rotation: -7.7
TER: 0.09%
AUM: 1.80B
Avg Turnover: 10.6M
Risk 3d forecast
Volatility4.37%
VaR 5th Pctl0.80%
VaR vs Median1.49%
Reward TTM
Sharpe Ratio-0.99
Rel. Str. IBD34.7
Rel. Str. Peer Group17.3 pctl
Character TTM
Beta0.112
Beta Downside0.091
Hurst Exponent0.528
Choppyness42.3%
Drawdowns 3y
Max DD4.73%
CAGR/Max DD1.38
CAGR/Mean DD5.06

Warnings

Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 4.2 years of data

Jan -0.2% 34
Feb +0.7% 16
Mar -1.1% 14
Apr -0.7% 14
May -0.2% 13
Jun +0.5% 25
Jul +0.2% 0
Aug +0.3% 0
Sep -1.2% 0
Oct -1.7% 36
Nov +0.5% 36
Dec -0.4% 11

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: IBDX Trust - iBonds Dec 2032

The iShares iBonds Dec 2032 Term Corporate ETF (IBDX) is a target maturity bond ETF that seeks to track an index composed of U.S. dollar-denominated corporate bonds maturing in 2032. The fund invests at least 80% of its assets in the component instruments of the underlying index and at least 90% of its assets in fixed income securities that BlackRock Fund Advisors (BFA) believes will help the fund replicate the indexs performance. To maintain index alignment, the fund may also allocate a portion of its holdings to non-U.S. issuers when necessary.

As part of iShares iBonds suite of target maturity ETFs, IBDX follows a defined-maturity structure, meaning the portfolio is designed to wind down and return principal as the underlying bonds reach their 2032 maturity date, distinguishing it from perpetual-duration bond funds.

Headlines to Watch Out For
  • Fed rate cuts compress corporate bond yields
  • AUM growth drives fee revenue as inflows accelerate
  • Credit spreads widen on recession fears
What is the price of IBDX shares?

As of November 03, 2026, the stock is trading at USD 24.29 with a total of 352,395 shares traded. Over the past week, the price has changed by +0.41%, over one month by +1.76%, over three months by -0.88% and over the past year by +0.13%.

Current recommended Stop Loss: 24.00 (which is 1.2% or 2.4 ATR below the current price).

Is IBDX a buy, sell or hold?

Trust - iBonds Dec 2032 has no consensus analysts rating.